Toronto Dominion Bank Acquires Shares of 540,024 Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Toronto Dominion Bank purchased a new stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 540,024 shares of the company's stock, valued at approximately $24,879,000. Toronto Dominion Bank owned 1.93% of Establishment Labs as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Quarry LP bought a new position in shares of Establishment Labs during the fourth quarter worth approximately $27,000. R Squared Ltd acquired a new stake in shares of Establishment Labs during the 4th quarter worth $36,000. KLP Kapitalforvaltning AS bought a new position in shares of Establishment Labs in the fourth quarter worth $161,000. Hood River Capital Management LLC raised its stake in Establishment Labs by 236.4% in the fourth quarter. Hood River Capital Management LLC now owns 5,920 shares of the company's stock valued at $273,000 after purchasing an additional 4,160 shares in the last quarter. Finally, Handelsbanken Fonder AB lifted its position in Establishment Labs by 32.3% during the fourth quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock worth $378,000 after purchasing an additional 2,000 shares during the period. 72.91% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Stephens reiterated an "overweight" rating and issued a $52.00 target price on shares of Establishment Labs in a research report on Thursday, March 6th. Wall Street Zen downgraded shares of Establishment Labs from a "hold" rating to a "sell" rating in a research note on Thursday. BTIG Research assumed coverage on shares of Establishment Labs in a research report on Friday, May 16th. They issued a "buy" rating and a $62.00 target price on the stock. Finally, Needham & Company LLC upgraded shares of Establishment Labs from a "hold" rating to a "buy" rating and set a $48.00 price target for the company in a report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, Establishment Labs has an average rating of "Moderate Buy" and a consensus target price of $55.33.

Establishment Labs Trading Up 2.7%

ESTA traded up $0.97 during trading on Thursday, reaching $36.85. 247,089 shares of the stock traded hands, compared to its average volume of 470,242. The stock has a market capitalization of $1.07 billion, a PE ratio of -14.28 and a beta of 0.73. The stock's 50-day moving average is $34.42 and its 200 day moving average is $38.10. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. Establishment Labs Holdings Inc. has a 12 month low of $26.56 and a 12 month high of $58.00.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported ($0.70) EPS for the quarter, beating analysts' consensus estimates of ($0.83) by $0.13. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. The firm had revenue of $41.38 million during the quarter, compared to analysts' expectations of $41.15 million. During the same quarter last year, the firm posted ($0.58) earnings per share. The company's revenue for the quarter was up 11.3% compared to the same quarter last year. Equities analysts anticipate that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.